The CRISPR-Cas9 Technologies Summit 2026 is a global, virtual forum created to advance meaningful progress in genome editing through science-driven dialogue and collaboration. As CRISPR-Cas9 technologies continue to reshape medicine, biotechnology, agriculture, and environmental science, the summit serves as a focused space where discovery meets real-world application.
Scheduled for December 9-10, 2026, the summit brings together researchers, clinicians, technologists, industry leaders, and policy specialists working at the forefront of gene-editing innovation. The program is designed to reflect the current state of the field-highlighting technical advances, translational successes, regulatory considerations, and ethical responsibilities that define modern CRISPR research.
The CRISPR-Cas9 Technologies Summit is designed to go beyond traditional online meetings. Built on a participant-centric design, the summit delivers a dynamic and interactive virtual program that maximizes meaningful engagement among speakers and attendees.
A fully virtual format enables broader global participation and collaboration among researchers and professionals worldwide, regardless of travel or funding constraints.
Special sessions highlight early-career researchers, students, and postdoctoral fellows, offering visibility, mentorship, and recognition.
The summit emphasizes CRISPR-Cas9 tools, technologies, and applications, bridging basic research, clinical translation, bioengineering, ethics, and commercialization.
Recorded sessions will be available on demand, allowing attendees to engage with content across time zones and schedules.
Rather than passive sessions, the program prioritizes discussion-based formats, Q&A sessions with live audience participation, networking, and collaborative learning.
Live sessions highlight the latest CRISPR-Cas9 clinical milestones, including CASGEVY’s global progress and emerging in vivo successes like CTX310.
The summit will cover a wide range of CRISPR-Cas9 advancements through themed sessions. Key topics include:
The CRISPR-Cas9 Technologies Summit offers flexible and affordable registration options designed to meet diverse needs. Participants can choose the package that best aligns with their goals and resources while gaining access to scientific sessions and networking opportunities. Secure your place at the summit with registration options tailored for individuals, students, and groups.
We invite submissions for oral presentations, poster presentations, and panel discussions. Abstracts should highlight original research or innovative applications in CRISPR-Cas9 technologies.
Abstracts must be 250–500 words and include the title, authors, affiliations, and keywords. Use 12-pt Arial font, single-spaced, and include the sections Background, Methods, Results, and Conclusions.
Submitted abstracts must be relevant to the summit themes, including CRISPR Biology and Mechanisms, Delivery Technologies and Targeted Editing, and Therapeutics and Clinical Applications, etc.
Submit abstracts via the online portal. Include a brief bio (100 words) for the presenting author.
All submissions will undergo internal review and will be evaluated based on originality, scientific merit, relevance, and clarity.
First-round submission deadline is September 15, 2026. Notifications will be issued on September 21, 2026. Late submissions may be accepted until November 10, 2026, subject to availability.
Virtual posters must be submitted in PDF format, landscape orientation (16:9 ratio) for interactive display.
Accepted abstracts may be published in conference proceedings or partnered journals.
For questions, email [email address].
The CRISPR-Cas9 Technologies Summit features a structured two-day program featuring keynote presentations, expert-led sessions, panel discussions, and interactive networking opportunities. On-demand recordings of all sessions will be available to registered participants.